Taken together, these results demonstrate that pterostilbene treatment inhibits tumor cell proliferation and angiogenesis and induces apoptosis in Pten-loss prostate tumors, at least in part, due to inhibition of MTA1. This evidence concerns the gene MTA1 and neoplasm.